Jiangu Capital
兼固资本
Jiangu Capital (兼固资本) is a Chinese venture capital fund that appears as a co-investor in growth-stage deals. It followed Qdama's nearly RMB 1 billion Series D round in late 2019, which was led by Cornerstone Capital with participation from Taikang Life, Qicheng Capital, and others . In early 2022, it also co-invested in Sibionics' C++ round of over RMB 500 million, led by CPE Source and China Life's Sci-Tech Innovation Fund .
elsewhere's corpus does not contain a dedicated profile of Jiangu Capital's founding, team, or overall strategy — the fund appears only in these co-investment references.
AI-generated — may contain errors, please verify.
Coverage
AI Medical Device Company "Silicon Based Bionics" Raises Over 800 Million Yuan in Three C-Round Tranches, Led by Source Code Capital
China's first CGM company to receive regulatory approval and achieve mass production without requiring finger-prick calibration
Gaorong News · December | Gaorong Ventures Named Among "China's Top 3 Best VC Funds of 2019," Ronghui "Youth Innovation Camp" Concludes
The future is bright.
Leading Community Fresh Food Brand "Qian Damayi" Closes Nearly RMB 1 Billion Series D Round | Gaorong Ventures News
Boosting efficiency and the customer experience in the fresh food industry, so every meal is truly fresh.
